> Strategic Planning for New Businesses
> Merger & Acquisition Advisory - Divestitures
> Merger & Acquisition Advisory - Acquisitions
> Capital raising

 

 

 

 

 

Walter Greenblatt & Associates Client Case Studies:

WuXi Pharmatech: Concept to IPO


Advanced BioHealing: Virtual Company to Fully-Funded Revenue-producing Biotech

 
Strategic Planning for New Businesses

Walter Greenblatt & Associates, LLC helps scientists and researchers to formulate effective plans to enter a new business in the biotechnology market, to make a well-reasoned go/no go decision based on this plan, and to communicate their vision effectively, meaning successfully, to potential providers of capital, partners, customers and suppliers.

Walter Greenblatt & Associates, LLC also helps biotechs to determine the value of their science and technology, as well as their business, and raise any capital required to implement the business plan.


Evaluate Potential of the Business and value of the science and technology

Outline Marketing Strategy

Estimate Investment Requirements

Project Five Year Financials

Perform Competitive Analysis

Establish Human Resource Needs

• Investigate Regulatory Issues

Design Optimal Capital Structure

• Outline Follow-Up Business Opportunities

• Devise Plans to Minimize Risks

Examine Possible Exit Strategies

Raise Debt and Equity Capital